Stockscreener 앱 받기
0.2488
3.49%
0.0084
In 8 Bio Inc 주식(INAB)의 최신 뉴스
Tolerance Bio, Inc. Announces Scientific Advisory Board and Completion of $20.2 Million Seed Round to Advance Thymus-Based Therapies for Immune-Mediated Diseases - Business Wire
Annovis Bio 8-K Filing Reveals Investor Update and Presentation Details - Defense World
INmune Bio Inc. Completes Repayment of Silicon Valley Bank Debt - The Manila Times
INmune Bio Strengthens Balance Sheet Ahead of Crucial Alzheimer's Trial Data, Clears $15M Debt - StockTitan
Hyderabad's Suven to acquire controlling stake in Princeton based NJ Bio, Inc - Deccan Herald
GRI Bio to Participate in the Virtual Investor Closing Bell Series - GlobeNewswire
PRUDENTIAL FINANCIAL INC's Strategic Acquisition of Cabaletta Bio Inc Shares - GuruFocus.com
bluebird bio Announces 1-for-20 Reverse Stock Split - Business Wire
/C O R R E C T I O N -- Today's Marketplace/ - Quantisnow
KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference - GlobeNewswire
Kronos Bio : Management Change/Compensation Form 8 K - Marketscreener.com
Attendee List for BevNET Live Winter 2024 - BevNET.com
Tevogen Bio Prepares Organizational Readiness to Support Company’s Growth Strategy - GlobeNewswire
Annovis to Host Year-End Investor Webcast on December 11, 2024 - Quantisnow
GRI Bio Showcases GRI-0621's Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF) - The Manila Times
GRI Bio Showcases GRI-0621’s Potential to Reduce - GlobeNewswire
Palisade Bio to Present Preclinical Results for PALI-2108 - GlobeNewswire
10 Biggest Biotechnology Companies - Investopedia
TāStation®'s analytical power used to resolve a central question about sweet taste perception - EurekAlert
Cabaletta Bio Presents Positive Clinical Safety and Efficacy Data on CABA-201 at ACR Convergence 2024 - The Manila Times
Intevac (NASDAQ: IVAC) Enters into Letter Agreement with Palogic Value Management, L.P.Santa Clara, CA, November 13, 2024 – Intevac, Inc. (NASDAQ: IVAC) disclosed today in a Form 8-K filing that on November 8, 2024, the company entered into a letter - Defense World
Sound Point Meridian Capital, Inc. (NYSE: SPMC) Announces Financial Results for Quarter Ended September 30, 2024 - Defense World
Roth CH Acquisition II Files 8-K Report with SEC Detailing Company Updates and Investor Presentation - Defense World
Capricor Therapeutics Announces Financial Results for Third Quarter 2024 and Strategic DevelopmentsSAN DIEGO, November 13, 2024 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR) recently disclosed its financial outcomes for the third - Defense World
Predictive Oncology Inc. Issues Press Release Detailing Financial Results for Q3 2024Predictive Oncology Inc., a leading biopharmaceutical company, released a pivotal press release detailing its financial results for the quarter ending September 30 - Defense World
Broadwind, Inc. Reports Financial Results for Quarter Ending September 30, 2024 - Defense World
Gritstone bio : Bankruptcy Form 8 K - Marketscreener.com
US$8.25: That's What Analysts Think 2seventy bio, Inc. (NASDAQ:TSVT) Is Worth After Its Latest Results - Yahoo Finance
bluebird bio, Inc. (NASDAQ:BLUE) Q3 2024 Earnings Call Transcript - Insider Monkey
bluebird bio Inc (BLUE) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ... - Yahoo Finance
SEC Form SC 13G filed by Bio-Rad Laboratories Inc. - Quantisnow
bluebird bio Reports Third Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance - BioSpace
Palisade Bio CMO Mitch Jones, MD, PhD, to Present at 8th Annual Antifibrotic Drug Development (AFDD) Summit - GlobeNewswire
NJ Bio, Inc. Wins Best CRO Award at 15th Annual World ADC Conference - Joplin Globe
Kronos Bio : Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic Alternatives Form 8 K - Marketscreener.com
FMR LLC Bolsters Stake in Nuvation Bio Inc - GuruFocus.com
Mustang Bio Receives Positive Listing Determination from Nasdaq - The Manila Times
Annovis Invited to Present at National Institute on Aging Workshop on Dementia with Lewy Bodies (DLB) - Quantisnow
2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress - Business Wire
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Annovis Bio Reports Third Quarter Financial Results and Provides Business Update - GlobeNewswire
Gossamer Bio, Inc. (NASDAQ:GOSS) Just Reported And Analysts Have Been Lifting Their Price Targets - Yahoo Finance
BioRestorative Therapies Enters at-the-Market Offering Agreement with Rodman & Renshaw LLC - Defense World
National Fuel Gas Updates Investor Presentation in Current ReportNational Fuel Gas Company (NYSE: NFG) has made notable updates to its Investor Presentation as detailed in a recent 8-K filing with the Securities and Exchange Commission on November - Defense World
BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES - The Malaysian Reserve
Annovis Bio Inc (ANVS) Quarterly 10-Q Report - Quartzy
Telesis Bio: Q3 Earnings Snapshot - New Haven Register
TELA Bio Inc (TELA) Quarterly 10-Q Report - Quartzy
Mustang Bio Inc (MBIO) Quarterly 10-Q Report - Quartzy
Pharma Pulse 11/8/24: Dusting Off One’s Cost Center Hat, Iron Supplements Benefit Children with HIV & more - Pharmaceutical Executive
Tevogen Bio Nears Finalization of Agreement to Enhance R&D and Manufacturing Capabilities; $36 Million Line of Credit Available for Continued Operations - Yahoo Finance
TELA Bio Reports Third Quarter 2024 Financial Results - The Bakersfield Californian
bluebird bio Adjourns Meeting of Stockholders and Announces Third Quarter 2024 Results Call - BioSpace
Secura Bio Announces Poster Presentation Highlighting New - GlobeNewswire
bluebird bio Adjourns Meeting of Stockholders and Announces Third Quarter Results Call - Business Wire
[Latest] Global Cancer Cell Analysis Market Size/Share - GlobeNewswire
Secura Bio Announces Poster Presentation Highlighting New COPIKTRA® (duvelisib) Data for the Treatment of Patients With Peripheral T-Cell Lymphoma and Other Advanced Hematologic Malignancies at the 2024 American Society of Hematology Meeting - The Manila Times
Nuvation Bio Inc. (NUVB): Promising Penny Stock with Strong Oncology Pipeline - Yahoo Finance
Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Company's Novel Business Model as Key to Sustainable Success through Patient Affordability - Quantisnow
2seventy bio to Report Third Quarter 2024 Financial Results and Participate in Upcoming Investor Conference - StockTitan
bluebird bio (BLUE): Promising Gene Editing Stock with FDA-Approved Therapies - Yahoo Finance
2.88%
2.65%
자본화:
|
볼륨(24시간):